Search Results - "Quartuccio, H."

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates by BELENA, R, TOOLAN, B. C, QUARTUCCIO, H, FIORAVANTI, C, CLAIR, J, BROWN, E, HAYES, W. C, RODAN, G. A, SHEA, M, MARKATOS, A, MYERS, E. R, LEE, S. C, OPAS, E. E, SEEDOR, J. G, KLEIN, H, FRANKENFIELD, D

“…This study examined the effect of 2 yr of treatment with the aminobisphosphonate alendronate (ALN) (0.05 or 0.25 mg/kg i.v. ALN every 2 wk) on estrogen…”
Get full text

The bisphosphonate alendronate (MK‐217) inhibits bone loss due to ovariectomy in rats by Seedor, J. Gregory, Quartuccio, Helen A., Thompson, David D.

“…Estrogen deficiency in mammals is known to increase bone turnover and result in reduced bone mass. The bisphosphonate,…”
Get full text

Effects of 4‐amino‐1‐hydroxybutylidene bisphosphonate on bone biomechanics in rats by Toolan, B.C., Shea, M., Myers, E.R., Borchers, R.E., Seedor, J.G., Quartuccio, H., Rodan, G., Hayes, W.C.

“…Bisphosphonates inhibit osteoclast‐mediated bone resorption, but their effects on the mechanical behavior of bone remain uncertain. This study investigated the…”
Get full text

Pattern of gene expression following rat tibial marrow ablation by Suva, Larry J., Seedor, Gregory J., Endo, Naoto, Quartuccio, Helen A., Thompson, David D., Bab, Itai, Rodan, Gideon A.

“…Following injury to bone marrow there is a phase of osteogenesis in which bone trabeculae replace the initial blood clot and fill the marrow cavity. The newly…”
Get full text

Impaired bone activity in aged rats: alterations at the cellular and molecular levels by Liang, C T, Barnes, J, Seedor, J G, Quartuccio, H A, Bolander, M, Jeffrey, J J, Rodan, G A

“…We have used a model of rapid bone induction and resorption in rats initiated by the removal of bone marrow to define age-associated deficits. Here we report…”
Get more information

The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons by Thompson, D.D., Seedor, J.G., Quartuccio, H., Solomon, H., Fioravanti, C., Davidson, J., Klein, H., Jackson, R., Clair, J., Frankenfield, D., Brown, E., Simmons, H.A., Rodan, G.A.

“…We examined the effect of the amino bisphosphonate alendronate, administered IV every 2 weeks at 0.05 and 0.25 mg/kg for 1 year, on bone loss and parameters…”
Get full text

Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys by Weinreb, M, Quartuccio, H, Seedor, J G, Aufdemorte, T B, Brunsvold, M, Chaves, E, Kornman, K S, Rodan, G A

“…This study tested the efficacy of alendronate, a bisphosphate, in reducing alveolar bone loss caused by experimental periodontitis in cynomolgus monkeys…”
Get more information

Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein by Fisher, J E, Caulfield, M P, Sato, M, Quartuccio, H A, Gould, R J, Garsky, V M, Rodan, G A, Rosenblatt, M

“…Osteoclastic bone resorption requires the formation of a tightly sealed compartment between the osteoclast and the mineralized bone matrix. This compartment…”
Get more information

The Biphosphonate Aledronate (MK‐217) Inhibits Bone Loss due to Ovariectomy in Rats by Seedor, JG, Quartuccio, HA, Thompson, DD

“…Estrogen deficiency in mammals is known to increase bone turnover and result in reduced bone mass. The bisphosphonate,…”
Get full text

The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats by SEEDOR, J. Gregory, QUARTUCCIO, Helen A, THOMPSON, David D

Get full text